title: [Phytotherapy in combined treatment of chronic infection of the upper urinary tract in patients exposed to extracorporeal shock-wave lithotripsy].
abstract: Multicomponent biologically active additive Uroprofit made by Russian company Ecomir is used for phytotherapy of urolithiasis and urogenital infectious and inflammatory processes. Of 60 patients with urolithiasis and chronic pyelonephritis exposed to extracorporeal shock-wave lithotripsy (ECSWL), 30 patients received additional anti-inflammatory therapy with Uroprofit. As shown by reduction of leukocyturia and crystalluria, increased 24-h diuresis in patients with urolithiasis after exposure to ECSWL, a positive effect was achieved on urethral inflammation. Thus, Uroprofit phytotherapy has antiinflammatory, diuretic, lithokinetic effects which makes it appropriate for treatment and prophylaxis of infectious-inflammatory process in the urethra.
authors.forename: V A
authors.initials: VA
authors.lastname: Maksimov
authors.forename: L A
authors.initials: LA
authors.lastname: Khodyreva
authors.forename: A A
authors.initials: AA
authors.lastname: Dudareva
authors.forename: A A
authors.initials: AA
authors.lastname: Serdiuk
mesh_terms: D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D008096:Lithotripsy; D008297:Male; D008875:Middle Aged; D008517:Phytotherapy; D028321:Plant Preparations / Q000008:administration & dosage*; D011704:Pyelonephritis / Q000150:complications / Q000628:therapy* / Q000652:urine; D013997:Time Factors; D014552:Urinary Tract Infections / Q000150:complications / Q000628:therapy* / Q000652:urine; D052878:Urolithiasis / Q000150:complications / Q000628:therapy* / Q000652:urine
chemical_list: D028321:Plant Preparations